ID   NGN1_HUMAN              Reviewed;         237 AA.
AC   Q92886; Q5U0Q9; Q96HE1;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2003, sequence version 2.
DT   18-JUN-2025, entry version 191.
DE   RecName: Full=Neurogenin-1;
DE            Short=NGN-1;
DE   AltName: Full=Class A basic helix-loop-helix protein 6;
DE            Short=bHLHa6;
DE   AltName: Full=Neurogenic basic-helix-loop-helix protein;
DE   AltName: Full=Neurogenic differentiation factor 3;
DE            Short=NeuroD3;
GN   Name=NEUROG1; Synonyms=BHLHA6, NEUROD3, NGN, NGN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8816493; DOI=10.1128/mcb.16.10.5792;
RA   McCormick M.B., Tamimi R.M., Snider L., Asakura A., Bergstrom D.,
RA   Tapscott S.J.;
RT   "NeuroD2 and neuroD3: distinct expression patterns and transcriptional
RT   activation potentials within the neuroD gene family.";
RL   Mol. Cell. Biol. 16:5792-5800(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   VARIANT CCDDRD LEU-116, AND INVOLVEMENT IN CCDDRD.
RX   PubMed=26077850; DOI=10.1007/s00439-015-1575-0;
RA   Yavarna T., Al-Dewik N., Al-Mureikhi M., Ali R., Al-Mesaifri F.,
RA   Mahmoud L., Shahbeck N., Lakhani S., AlMulla M., Nawaz Z., Vitazka P.,
RA   Alkuraya F.S., Ben-Omran T.;
RT   "High diagnostic yield of clinical exome sequencing in Middle Eastern
RT   patients with Mendelian disorders.";
RL   Hum. Genet. 134:967-980(2015).
RN   [6]
RP   VARIANT CCDDRD 68-GLU--HIS-237 DEL, AND INVOLVEMENT IN CCDDRD.
RX   PubMed=33439489; DOI=10.1111/cge.13922;
RA   Dupont J., Vieira J.P., Tavares A.L.T., Conceicao C.R., Khan S.,
RA   Bertoli-Avella A.M., Sousa A.B.;
RT   "Adding evidence to the role of NEUROG1 in congenital cranial
RT   dysinnervation disorders.";
RL   Clin. Genet. 99:588-593(2021).
CC   -!- FUNCTION: Acts as a transcriptional regulator. Involved in the
CC       initiation of neuronal differentiation. Activates transcription by
CC       binding to the E box (5'-CANNTG-3'). Associates with chromatin to
CC       enhancer regulatory elements in genes encoding key transcriptional
CC       regulators of neurogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:P70660}.
CC   -!- SUBUNIT: Efficient DNA binding requires dimerization with another bHLH
CC       protein.
CC   -!- INTERACTION:
CC       Q92886; P02489: CRYAA; NbExp=3; IntAct=EBI-10279647, EBI-6875961;
CC       Q92886; Q14204: DYNC1H1; NbExp=3; IntAct=EBI-10279647, EBI-356015;
CC       Q92886; Q92876: KLK6; NbExp=3; IntAct=EBI-10279647, EBI-2432309;
CC       Q92886; Q99081-3: TCF12; NbExp=3; IntAct=EBI-10279647, EBI-11952764;
CC       Q92886; P15884: TCF4; NbExp=4; IntAct=EBI-10279647, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expression restricted to the embryonic nervous
CC       system.
CC   -!- DISEASE: Cranial dysinnervation disorder, congenital, with absent
CC       corneal reflex and developmental delay (CCDDRD) [MIM:620469]: An
CC       autosomal recessive form of congenital cranial dysinnervation disorder.
CC       This term defines a heterogeneous group of neurodevelopmental disorders
CC       caused by a primary disturbance of innervation due to deficient,
CC       absent, or misguided cranial nerves. CCDDRD is characterized by
CC       developmental delay, corneal opacity, absent corneal reflex,
CC       expressionless face with asymmetry, sensorineural hearing loss,
CC       trigeminal nerve hypoplasia, and bilateral agenesis or severe
CC       hypoplasia of the VIII nerve with marked atresia of the internal
CC       auditory canals and cochlear labyrinth malformation. Additional
CC       features include hypotonia, impaired intellectual development, and
CC       behavioral abnormalities. {ECO:0000269|PubMed:26077850,
CC       ECO:0000269|PubMed:33439489}. Note=The disease may be caused by
CC       variants affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U63842; AAB37575.1; -; Genomic_DNA.
DR   EMBL; BT019366; AAV38173.1; -; mRNA.
DR   EMBL; CH471062; EAW62214.1; -; Genomic_DNA.
DR   EMBL; BC008687; AAH08687.1; -; mRNA.
DR   EMBL; BC028226; AAH28226.1; -; mRNA.
DR   CCDS; CCDS4187.1; -.
DR   RefSeq; NP_006152.2; NM_006161.2.
DR   AlphaFoldDB; Q92886; -.
DR   SMR; Q92886; -.
DR   BioGRID; 110835; 16.
DR   FunCoup; Q92886; 883.
DR   IntAct; Q92886; 16.
DR   STRING; 9606.ENSP00000317580; -.
DR   iPTMnet; Q92886; -.
DR   PhosphoSitePlus; Q92886; -.
DR   BioMuta; NEUROG1; -.
DR   DMDM; 37538313; -.
DR   MassIVE; Q92886; -.
DR   PaxDb; 9606-ENSP00000317580; -.
DR   PeptideAtlas; Q92886; -.
DR   Antibodypedia; 26408; 615 antibodies from 35 providers.
DR   DNASU; 4762; -.
DR   Ensembl; ENST00000314744.6; ENSP00000317580.4; ENSG00000181965.6.
DR   GeneID; 4762; -.
DR   KEGG; hsa:4762; -.
DR   MANE-Select; ENST00000314744.6; ENSP00000317580.4; NM_006161.3; NP_006152.2.
DR   UCSC; uc003lax.3; human.
DR   AGR; HGNC:7764; -.
DR   CTD; 4762; -.
DR   DisGeNET; 4762; -.
DR   GeneCards; NEUROG1; -.
DR   HGNC; HGNC:7764; NEUROG1.
DR   HPA; ENSG00000181965; Not detected.
DR   MalaCards; NEUROG1; -.
DR   MIM; 601726; gene.
DR   MIM; 620469; phenotype.
DR   OpenTargets; ENSG00000181965; -.
DR   VEuPathDB; HostDB:ENSG00000181965; -.
DR   eggNOG; KOG3898; Eukaryota.
DR   GeneTree; ENSGT00940000162170; -.
DR   HOGENOM; CLU_097959_0_0_1; -.
DR   InParanoid; Q92886; -.
DR   OMA; EDYCYGP; -.
DR   OrthoDB; 5969565at2759; -.
DR   PAN-GO; Q92886; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q92886; -.
DR   PathwayCommons; Q92886; -.
DR   SignaLink; Q92886; -.
DR   SIGNOR; Q92886; -.
DR   BioGRID-ORCS; 4762; 13 hits in 1158 CRISPR screens.
DR   GeneWiki; NEUROG1; -.
DR   GenomeRNAi; 4762; -.
DR   Pharos; Q92886; Tbio.
DR   PRO; PR:Q92886; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q92886; protein.
DR   Bgee; ENSG00000181965; Expressed in ganglionic eminence and 3 other cell types or tissues.
DR   ExpressionAtlas; Q92886; baseline and differential.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; EXP:DisProt.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0070888; F:E-box binding; IDA:CAFA.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:CAFA.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:CAFA.
DR   GO; GO:0031223; P:auditory behavior; IGI:CAFA.
DR   GO; GO:0061564; P:axon development; IBA:GO_Central.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0090102; P:cochlea development; IGI:CAFA.
DR   GO; GO:0090103; P:cochlea morphogenesis; IGI:CAFA.
DR   GO; GO:0097094; P:craniofacial suture morphogenesis; IGI:CAFA.
DR   GO; GO:0010458; P:exit from mitosis; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IBA:GO_Central.
DR   GO; GO:0048806; P:genitalia development; IGI:CAFA.
DR   GO; GO:0035112; P:genitalia morphogenesis; IGI:CAFA.
DR   GO; GO:1905748; P:hard palate morphogenesis; IGI:CAFA.
DR   GO; GO:0048839; P:inner ear development; IGI:CAFA.
DR   GO; GO:0042472; P:inner ear morphogenesis; IGI:CAFA.
DR   GO; GO:0098583; P:learned vocalization behavior; IGI:CAFA.
DR   GO; GO:0071626; P:mastication; IGI:CAFA.
DR   GO; GO:1901078; P:negative regulation of relaxation of muscle; IGI:CAFA.
DR   GO; GO:1905747; P:negative regulation of saliva secretion; IGI:CAFA.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IGI:CAFA.
DR   GO; GO:0030432; P:peristalsis; IGI:CAFA.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0031536; P:positive regulation of exit from mitosis; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0048634; P:regulation of muscle organ development; IGI:CAFA.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0007423; P:sensory organ development; IBA:GO_Central.
DR   GO; GO:0007356; P:thorax and anterior abdomen determination; IGI:CAFA.
DR   GO; GO:0021559; P:trigeminal nerve development; IGI:CAFA.
DR   GO; GO:0021650; P:vestibulocochlear nerve formation; IGI:CAFA.
DR   CDD; cd19716; bHLH_TS_NGN1_NeuroD3; 1.
DR   DisProt; DP00672; -.
DR   FunFam; 4.10.280.10:FF:000006; Neurogenic differentiation factor; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR050359; bHLH_transcription_factors.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   PANTHER; PTHR19290; BASIC HELIX-LOOP-HELIX PROTEIN NEUROGENIN-RELATED; 1.
DR   PANTHER; PTHR19290:SF130; NEUROGENIN-1; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   neXtProt; NX_Q92886; -.
DR   PharmGKB; PA31569; -.
DR   TreeFam; TF315153; -.
PE   1: Evidence at protein level;
KW   Activator; Deafness; Developmental protein; Differentiation;
KW   Disease variant; DNA-binding; Intellectual disability; Neurogenesis;
KW   Nucleus; Proteomics identification; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..237
FT                   /note="Neurogenin-1"
FT                   /id="PRO_0000127396"
FT   DOMAIN          92..144
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          35..83
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          175..209
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        38..53
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        180..207
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         68..237
FT                   /note="Missing (in CCDDRD; likely pathogenic)"
FT                   /evidence="ECO:0000269|PubMed:33439489"
FT                   /id="VAR_088842"
FT   VARIANT         116
FT                   /note="R -> L (in CCDDRD; uncertain significance)"
FT                   /evidence="ECO:0000269|PubMed:26077850"
FT                   /id="VAR_088843"
FT   CONFLICT        51
FT                   /note="G -> S (in Ref. 1; AAB37575)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   237 AA;  25718 MW;  E3702A0B3408D567 CRC64;
     MPARLETCIS DLDCASSSGS DLSGFLTDEE DCARLQQAAS ASGPPAPARR GAPNISRASE
     VPGAQDDEQE RRRRRGRTRV RSEALLHSLR RSRRVKANDR ERNRMHNLNA ALDALRSVLP
     SFPDDTKLTK IETLRFAYNY IWALAETLRL ADQGLPGGGA RERLLPPQCV PCLPGPPSPA
     SDAESWGSGA AAASPLSDPS SPAASEDFTY RPGDPVFSFP SLPKDLLHTT PCFIPYH
//
